Key facts
- It has raised $250K; the latest was Out of Business in Apr 2026.
- Status: Out of Business.
- ·Watchlist + deal alerts for EmicAi
- ·The full record, as it builds
Funding rounds
No funding rounds for EmicAi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EmicAi
Developer of artificial intelligence-powered insights platform designed to enhance therapy commercialization by understanding the decision-making of healthcare professionals. The company's platform offers disease landscaping, biomarker analysis, patient journey mapping, prescribing behavior analysis, treatment protocol evaluation, market access assessment, demand modeling, adoption forecasting, performance tracking, and competitive dynamics analysis, enabling oncologists to optimize strategies and share expertise conveniently and securely.
- Sector
- Healthcare
- HQ
- Vancouver, Canada
- Founded
- 2023
- Employees
- 3
- Website
- emic.ai/
- Ownership
- Out of Business
EmicAi doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EmicAi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EmicAi in its N-PORT filings yet. We sweep new filings monthly.